ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-703-0084, 6505017030084
CORONAVIRUS VACCINE

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 017030084
Codification Country
United States
Item Name Code
INC 80837
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-703-0084
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-703-0084


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-703-0084

National Stock Number (NSN) 6505-01-703-0084, or NIIN 017030084, (coronavirus vaccine) was assigned August 11, 2022 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

This NSN is assigned to Item Name Code (INC) 80837. [TO BE ADMINISTERED TO HUMANS TO PROVIDE ACQUIRED IMMUNITY AGAINST CORONA VIRUS DISEASE; TO INCLUDE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS TYPE 2 (SARS-COV-2 ), SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS (SARS-COV) AND MIDDLE EAST RESPIRATORY SYNDROME CORONA VIRUS (MERS-COV).]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505017030084 does not contain precious metals.

This information was last updated on .


Technical Characteristics

PRIMARY CONTAINER TYPE
(CQCT) VIAL, MULTIPLE DOSE
SPECIAL FEATURES
(FEAT) INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (CCOVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER; ADMINISTERED INTRAMUSCULARLY AS A SERIES OF TWO DOSES (0.5 ML EACH) ONE MONTH APART; STORE FROZE BETWEEN -50C TO -15C (-58F TO 5F); DURING STORAGE, MINIMIZE EXPOSURE TO ROOM LIGHT, AND AVOID EXPOSURE TO DIRECT SUNLIGHT AND ULTRAVIOLET LIGHT; DISCARD 12 HOURS AFTER THE FIRST PUNCTURE; DO NOT REFREEZE; BOX OF 10 MULTI-DOSE VIAL (EACH VIAL CONTAINS 5.5ML); CONTAINS NO PRESERVATIVE; VIAL STOPPER NOT MADE WITH NATURAL RUBBER LATEX.
STORAGE TEMP RANGE
(AFJQ) -50.0/-15.0 DEG CELSIUS
VIRUS STRAIN
(CMDM) COVID-19
PROTECTIVE STORAGE FEATURE
(AJCN) PROTECT FROM LIGHT"
PRIMARY CONTAINER CONTENT QUANTITY
(CRLK) 5.5 MILLILITERS
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) MODERNA SPIKEVAX COVID-19 VACCINE, MULTI-DOSE VIAL 5.5ML, 10S
ADMINISTRATION
(CSGS) INJECTION
TOTAL PRIMARY CONTAINER QUANTITY
(CSCW) 10

Manufacturer Part Numbers


Related Inventory

s2600b
5961001637153
Condition NS
semiconductor
Readily Available
1340520
4820011637153
Condition NS
VALVE SAFETY
Readily Available


 
Top